Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
DNA Ginkgo Bioworks Holdings Inc
- Stocks
- Healthcare
- NYSE: DNA
Price (delayed)
$7.79
Market cap
$455.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$9.12
Enterprise value
$578.1M
the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline
Highlights
The EPS rose by 48% year-on-year and by 13% since the previous quarter
The net income has grown by 45% YoY and by 14% from the previous quarter
The debt has soared by 85% year-on-year
The equity is down by 34% year-on-year and by 10% since the previous quarter
Key stats
What are the main financial stats of DNA
Market
Valuations
Earnings
Shares outstanding
58.53M
Market cap
$455.96M
Enterprise value
$578.1M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.7
Price to sales (P/S)
1.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.43
Revenue
$237.42M
Gross profit
$190.02M
Operating income
-$470.72M
Net income
-$472.08M
EBIT
-$472.4M
EBITDA
-$377.05M
Free cash flow
-$344.65M
Per share
Balance sheet
Liquidity
EPS
-$9.12
EPS diluted
-$9.12
Free cash flow per share
-$6.35
Book value per share
$11.16
Revenue per share
$4.38
TBVPS
$22.58
Total assets
$1.29B
Total liabilities
$646.04M
Debt
$434.56M
Equity
$647.43M
Working capital
$448.87M
Debt to equity
0.67
Current ratio
4.88
Quick ratio
4.7
Net debt/EBITDA
-0.32
Margins
Efficiency
Dividend
EBITDA margin
-158.8%
Gross margin
80%
Net margin
-198.8%
Operating margin
-198.3%
Return on assets
-32.7%
Return on equity
-63.1%
Return on invested capital
-41.9%
Return on capital employed
-40.1%
Return on sales
-199%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DNA stock price
How has the Ginkgo Bioworks Holdings stock price performed over time
Intraday
-1.02%
1 week
10.65%
1 month
14.9%
1 year
-78.83%
YTD
-20.67%
QTD
36.67%
Financial performance
How have Ginkgo Bioworks Holdings's revenue and profit performed over time
Revenue
$237.42M
Gross profit
$190.02M
Operating income
-$470.72M
Net income
-$472.08M
Gross margin
80%
Net margin
-198.8%
The net margin has soared by 51% year-on-year and by 17% since the previous quarter
DNA's operating margin is up by 50% YoY and by 20% from the previous quarter
The net income has grown by 45% YoY and by 14% from the previous quarter
DNA's operating income is up by 43% year-on-year and by 16% since the previous quarter
Price vs fundamentals
How does DNA's price correlate with its fundamentals
Growth
What is Ginkgo Bioworks Holdings's growth rate over time
Valuation
What is Ginkgo Bioworks Holdings stock price valuation
P/E
N/A
P/B
0.7
P/S
1.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.43
The EPS rose by 48% year-on-year and by 13% since the previous quarter
The price to book (P/B) is 80% lower than the 5-year quarterly average of 3.5
The equity is down by 34% year-on-year and by 10% since the previous quarter
The stock's price to sales (P/S) is 93% less than its 5-year quarterly average of 26.0 and 22% less than its last 4 quarters average of 2.3
The revenue rose by 14% year-on-year and by 4.6% since the previous quarter
Efficiency
How efficient is Ginkgo Bioworks Holdings business performance
The company's return on invested capital has surged by 55% YoY and by 24% QoQ
The return on sales has surged by 51% year-on-year and by 17% since the previous quarter
The company's return on assets rose by 27% YoY and by 9% QoQ
The ROE has grown by 11% YoY and by 3.8% from the previous quarter
Dividends
What is DNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DNA.
Financial health
How did Ginkgo Bioworks Holdings financials performed over time
Ginkgo Bioworks Holdings's total assets is 100% higher than its total liabilities
Ginkgo Bioworks Holdings's total assets has decreased by 18% YoY and by 6% QoQ
DNA's quick ratio is down by 14% since the previous quarter and by 8% year-on-year
The debt is 33% smaller than the equity
The debt to equity has soared by 179% YoY and by 10% from the previous quarter
The debt has soared by 85% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.